To read the full recap, click here.
CRAACO convened over 100 leaders from hospital and healthcare systems, pharma organizations, and sites to present case studies, have thought-provoking discussions and listen to incredible keynotes all on how to embed clinical trials where patients receive care, and build the needed structure to run clinical research.
Dr Christina Brennan, Northwell Health, traced the journey of clinical research as a care option over the past decade. Keynote Dr Brian Slomovitz presented how Mount Sinai Medical Center Miami Beach had intertwined clinical research into a community cancer center and remained competitive amongst other hospitals.
Nick Slack, The START Center for Cancer Research, spoke about embedding clinical research staff into partnering healthcare organizations to provide patients with access to oncology trials. Dr Emily Ray Ko, Duke Regional Hospital, presented about how her hospital had built the necessary blocks for clinical research, and spoke with Manatt Health’s Donna O’Brien about how health systems can make trials more productive.
Dr Karen Knudsen, Parker Institute for Cancer Immunotherapy, and Kent Thoelke, Paradigm Health, underscored how technology reduced the trial administrative burden to staff and integrated clinical trials into physician workflows. Joe Lengfellner, Memorial Sloan Kettering Cancer Center, and Sebastien Rhodes, Triomics, spoke about clinical trial matching for oncology trials.
Keynote Dr Laura Esserman, University of California, San Francisco, highlighted how her I-SPY trial had turned the clinical environment into a learning health system, to provide breast cancer patients with cutting-edge therapeutics.
High-level panel discussions focused on two of the biggest challenges and trends of the industry. The first outlined how pharma can partner with multi-location health system structures to do research. The second focused on how to engage medical staff and build in the proper support for doing clinical research.
Nadir Ammour, Sanofi, and Dr Colleen Tenan Purcell, spoke about matching patients to clinical trials with AI and scaling up eSource EHR data collection. Dr Ali Abbasi, University of California, San Francisco, gave the CRAACO audience insights into how to create a data infrastructure that enabled the integration of care and research.
Todd McGrath, MRN, Dr Elizabeth Johnson, University of Montana, and Dr J. Kaitlin Morrison, University of South Carolina, Chapel Hill, each presented their unique way of bringing clinical trials directly to patients in rural, frontier and community settings. Jeff James, Wilmington Health System, and Dr Maureen Canavan, Yale, spoke about measuring the value of CRAACO, and the potential cost-savings of clinical trials in care centers. Merck’s Adam Kinsey, co-chair of the CRAACO conference, closed the day with key lessons, key learnings, and future next steps.
This year’s CRAACO shared networking with its sister event, Partnerships with Sites. Next year, we plan to combine both events to further help the industry’s goal of strengthening community-based clinical trials and to maximize networking. Going forward, we will be doing a quarterly editorial roundup under the branding of Partnerships with Sites that provides a broader range of content that supports community-based clinical trials.
